Dang Gui Yin Zi
Natural health product licensed in Canada
- Licence holder
- Hummingbird Medical Tech Inc.
- NPN or DIN-HM
- 80103991
- Status
- Active licence
- Licence date
- 8 September 2020
- Revision date
- Not provided
- Form
- Granules
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Angelica sinensis Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Paeonia lactiflora Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Ligusticum sinense cv. chuanxiong Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Rehmannia glutinosa Source : Tubercule Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Saposhnikovia divaricata Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Nepeta tenuifolia Source : Sommité Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Reynoutria multiflora Source : Tubercule Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 mg | 20 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 mg | 20 mg | Not calculated |
| Glycyrrhiza glabra Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 mg | 20 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 300 mg | 60 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2,000 mg | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80103991
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.